FSD Pharma

HUGE49

Penny Stock

$4.60arrow_drop_up17.29%$0.67

Penny Stock

HUGE49

$4.60

arrow_drop_up17.29%$0.67

Penny Stock

Performance History

Key Stats
Open	$3.86
Prev. Close	$3.92
EPS	-16.25
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$66.67K
PE Ratio	-

	LOW	HIGH
Day Range	3.86	4.74
52 Week Range	3.50	97.50

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-16.25

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About FSD Pharma (HUGE)

FSD Pharma Inc (HUGE) is a pharmaceutical research and development company. The company focuses on the use of cannabinoid-based therapies for various medical conditions. FSD Pharma is committed to conducting rigorous scientific research to understand the potential benefits of cannabinoids and develop novel therapeutic options. The company's stock price history has shown volatility, with fluctuations in response to market conditions and industry developments. Investors should carefully consider the risks and potential rewards of investing in FSD Pharma.

As of [date], FSD Pharma Inc (HUGE) has a market cap of [market cap], reflecting the company's total market value based on its stock price and outstanding shares. The company's PEG ratio, which measures the relationship between the stock's price-to-earnings ratio and its expected growth rate, provides insight into its valuation relative to expected future earnings growth. FSD Pharma Inc's PEG ratio [value] suggests [analysis].

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Mr. Zeeshan Saeed
Headquarters: Toronto
Employees: 17
Exchange: NASDAQ

Keep an eye on FSD Pharma

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is FSD Pharma 's (HUGE) price per share?

The current price per share for FSD Pharma (HUGE) is $4.6. The stock has seen a price change of $0.68 recently, indicating a 17.29% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for FSD Pharma (HUGE)?

For FSD Pharma (HUGE), the 52-week high is $97.5, which is 2.02K% from the current price. The 52-week low is $3.5, the current price is 31.43% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is FSD Pharma (HUGE) a growth stock?

FSD Pharma (HUGE) has shown an average price growth of -3.66% over the past three years. It has received a score of 92 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying FSD Pharma as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is FSD Pharma (HUGE) stock price performance year to date (YTD)?

As of the latest data, FSD Pharma (HUGE) has a year-to-date price change of -92.14%. Over the past six months, the figure is -79.77%.

help

Is FSD Pharma (HUGE) a profitable company?

FSD Pharma (HUGE) has a net income of -$18.56M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$19.93M. Furthermore, the EBITDA is -$10.2M.

help

What is the market capitalization of FSD Pharma (HUGE)?

FSD Pharma (HUGE) has a market capitalization of $66.67K. The average daily trading volume is 57.93K, indicating the stock's liquidity and investor engagement.

News

HEALTH

PRODUCT / SERVICES ANNOUNCEMENT

Sep 22, 2023

InvestmentPitch Media Video Discusses FSD Pharma’s Continued Development of its Exciting New Rapid Detox Drink UNBUZZD™, with Video Comments from Kevin Harrington

PRODUCT / SERVICES ANNOUNCEMENT

Aug 3, 2023

InvestmentPitch Media Video Features FSD Pharma’s Definitive Agreement Granting Exclusive Rights for Launch of UNBUZZD, a Revolutionary Rapid Alcohol Detoxification Drink

CORPORATE ACTION

DIRECTORS AND OFFICERS

Jun 23, 2023

InvestmentPitch Media Video Discusses FSD Pharma’s Granting of Exclusive Rights to Revolutionary Recreational Alcohol Misuse Technology to Celly Nutrition

MANAGEMENT STATEMENTS

May 16, 2023

InvestmentPitch Media Video Discusses FSD Pharma’s Cost Award of $2.81 Million from Dr. Raza Bokhari in an Arbitration Settlement

EXCLUSIVE: Investing In The Unique Growth Market Of Psychedelics

HEALTH

PRODUCT / SERVICES ANNOUNCEMENT

Mar 1, 2023

InvestmentPitch Media Video Discusses FSD Pharma’s Addition of Kevin Harrington, Author, “Shark Tank” Original, and Infomercial Pioneer to its Advisory Board

Performance History

Score Breakdown

Welcome to Stocklytics

Analyst Forecast

Analyst Ratings

About FSD Pharma (HUGE)

Keep an eye on FSD Pharma

Frequently Asked Questions

What is FSD Pharma 's (HUGE) price per share?

What is the 52-week high and low for FSD Pharma (HUGE)?

Is FSD Pharma (HUGE) a growth stock?

What is FSD Pharma (HUGE) stock price performance year to date (YTD)?

Is FSD Pharma (HUGE) a profitable company?

What is the market capitalization of FSD Pharma (HUGE)?

News

Take Your Investments to a Whole New Level